Page last updated: 2024-12-06

fenoctimine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Fenoctimine is a tricyclic antidepressant (TCA) with a chemical structure similar to amitriptyline. It has been investigated for its potential therapeutic effects in conditions such as depression, anxiety, and obsessive-compulsive disorder (OCD). However, its clinical use has been limited due to its side effects, including sedation, anticholinergic effects, and potential for cardiovascular complications. Fenoctimine's mechanism of action is thought to involve the inhibition of neuronal reuptake of serotonin and norepinephrine. Research on fenoctimine has focused on its potential benefits and risks in treating mood disorders and other psychiatric conditions. While it has shown some promise in preliminary studies, further research is needed to establish its safety and efficacy.'

fenoctimine: structure & RN from first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID50455
CHEMBL ID150283
SCHEMBL ID10857767
SCHEMBL ID1532751
MeSH IDM0114178

Synonyms (15)

Synonym
fenoctimine
CHEMBL150283
1-(4-benzhydrylpiperidin-1-yl)-n-octylmethanimine
b45cf873f8 ,
69365-65-7
fenoctimine [inn]
unii-b45cf873f8
piperidine, 4-(diphenylmethyl)-1-((octylimino)methyl)-, hemihydrate
4-(diphenylmethyl)-1-(n-octylformimidoyl)piperidine, hemihydrate
SCHEMBL10857767
SCHEMBL1532751
1-[4-[di(phenyl)methyl]piperidin-1-yl]-n-octylmethanimine
Q27274335
DTXSID30867820
1-[4-(diphenylmethyl)piperidin-1-yl]-n-octylmethanimine

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" These results emphasize the need for pilot toxicity studies, especially when components of the test system are varied, to assess the effect of drug concentration on the toxic response."( Alterations of drug-induced toxicity in the mouse lymphoma assay by a rat hepatic microsomal metabolizing system (S-9).
Oldham, JW; Paulson, JD; Preston, RF; Pritchard, JF, 1984
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID176287Antisecretory activity was evaluated in acute gastric fistula of rat after intravenous administration1987Journal of medicinal chemistry, May, Volume: 30, Issue:5
Antisecretory activity of human, dog, and rat metabolites of fenoctimine.
AID78012Anticholinergic activity was determined in vitro by measuring their effect on the acetylcholine chloride induced contraction of guinea pig ileum1987Journal of medicinal chemistry, May, Volume: 30, Issue:5
Antisecretory activity of human, dog, and rat metabolites of fenoctimine.
AID176283Antisecretory activity was evaluated in acute gastric fistula of rat after intraperitoneal administration1987Journal of medicinal chemistry, May, Volume: 30, Issue:5
Antisecretory activity of human, dog, and rat metabolites of fenoctimine.
AID176290Antisecretory activity was evaluated in acute gastric fistula of rat after peroral administration1987Journal of medicinal chemistry, May, Volume: 30, Issue:5
Antisecretory activity of human, dog, and rat metabolites of fenoctimine.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (81.82)18.7374
1990's2 (18.18)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (9.09%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]